|
1
|
Siegel RL: Cancer statistics, 2016. CA
Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas N; Cancer Genome Atlas
Network: Comprehensive molecular portraits of human breast tumours.
Nature. 490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends - an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar
|
|
4
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar
|
|
6
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng R, Lin S, Guan L, Yuan H, Liu K, Liu
C, Ye W, Liao Y, Jia J and Zhang R: Long non-coding RNA XIST
inhibited breast cancer cell growth, migration, and invasion via
miR-155/CDX1 axis. Biochem Biophys Res Commun. 498:1002–1008. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar :
|
|
9
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH,
Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28
reciprocal negative regulatory circuit promotes breast cancer stem
cell maintenance. Cell Death Dis. 8:e25692017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu X, Li Z, Zheng H, Chan MT and Wu WK:
NEAT1: A novel cancer-related long non-coding RNA. Cell Prolif.
50:502017.
|
|
11
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
14
|
Pang Y, Liu J, Li X, Xiao G, Wang H, Yang
G, Li Y, Tang SC, Qin S, Du N, et al: MYC and DNMT3A-mediated DNA
methylation represses microRNA-200b in triple negative breast
cancer. J Cell Mol Med. 22:6262–6274. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar
|
|
16
|
Lu Y, Yue X, Cui Y, Zhang J and Wang K:
MicroRNA-124 suppresses growth of human hepatocellular carcinoma by
targeting STAT3. Biochem Biophys Res Commun. 441:873–879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu DH, Liang H and Lu SN: miR-124
suppresses pancreatic ductal adenocarcinoma growth by regulating
monocarboxylate transporter 1-mediated cancer lactate metabolism.
Cell Physiol Biochem. 50:924–935. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang M, Meng B and Liu Y, Yu J, Chen Q and
Liu Y: miR-124 inhibits growth and enhances radiation-induced
apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell
Physiol Biochem. 44:2017–2028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M,
Yu XT, Cao DX, Chen GQ, He JR and Zhao Q: miR-124 targets Slug to
regulate epithelial-mesenchymal transition and metastasis of breast
cancer. Carcinogenesis. 34:713–722. 2013. View Article : Google Scholar
|
|
20
|
Cai WL, Huang WD, Li B, Chen TR, Li ZX,
Zhao CL, Li HY, Wu YM, Yan WJ and Xiao JR: microRNA-124 inhibits
bone metastasis of breast cancer by repressing Interleukin-11. Mol
Cancer. 17:92018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen SM, Chou WC, Hu LY, Hsiung CN, Chu
HW, Huang YL, Hsu HM, Yu JC and Shen CY: The effect of microRNA-124
overexpression on anti-tumor drug sensitivity. PLoS One.
10:e01284722015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu Y and Xiong J: MicroRNA-124 enhances
response to radiotherapy in human epidermal growth factor receptor
2-positive breast cancer cells by targeting signal transducer and
activator of transcription 3. Croat Med J. 57:457–464. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Holliday DL and Speirs V: Choosing the
right cell line for breast cancer research. Breast Cancer Res.
13:2152011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pang Y, Liu J, Li X, Zhang Y, Zhang B,
Zhang J, Du N, Xu C, Liang R, Ren H, et al: Nano Let-7b
sensitization of eliminating esophageal cancer stem-like cells is
dependent on blockade of Wnt activation of symmetric division. Int
J Oncol. 51:1077–1088. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Liu J, Li X, Wang M, Xiao G, Yang G, Wang
H, Li Y, Sun X, Qin S, Du N, et al: A miR-26a/E2F7 feedback loop
contributes to tamoxifen resistance in ER-positive breast cancer.
Int J Oncol. 53:1601–1612. 2018.PubMed/NCBI
|
|
27
|
Fang L, Sun J, Pan Z, Song Y, Zhong L,
Zhang Y, Liu Y, Zheng X and Huang P: Long non-coding RNA NEAT1
promotes hepatocellular carcinoma cell proliferation through the
regulation of miR-129-5p-VCP-IκB. Am J Physiol Gastrointest Liver
Physiol. 313:G150–G156. 2017. View Article : Google Scholar
|
|
28
|
Li Y, Li Y, Chen W, He F, Tan Z, Zheng J,
Wang W, Zhao Q and Li J: NEAT expression is associated with tumor
recurrence and unfavorable prognosis in colorectal cancer.
Oncotarget. 6:27641–27650. 2015.PubMed/NCBI
|
|
29
|
Zhao D, Zhang Y, Wang N and Yu N: NEAT1
negatively regulates miR-218 expression and promotes breast cancer
progression. Cancer Biomark. 20:247–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Wang S, Li Z, Long X, Guo Z, Zhang
G, Zu J, Chen Y and Wen L: The lncRNA NEAT1 facilitates cell growth
and invasion via the miR-211/HMGA2 axis in breast cancer. Int J
Biol Macromol. 105:346–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li W, Zhang Z, Liu X, Cheng X, Zhang Y,
Han X, Zhang Y, Liu S, Yang J, Xu B, et al: The FOXN3-NEAT1-SIN3A
repressor complex promotes progression of hormonally responsive
breast cancer. J Clin Invest. 127:3421–3440. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y and Cheng C: Long noncoding RNA NEAT1
promotes the metastasis of osteosarcoma via interaction with the
G9a DNMT1-Snail complex. Am J Cancer Res. 8:81–90. 2018.
|
|
33
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and microRNAs in health and disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qian K, Liu G, Tang Z, Hu Y, Fang Y, Chen
Z and Xu X: The long non-coding RNA NEAT1 interacted with miR-101
modulates breast cancer growth by targeting EZH2. Arch Biochem
Biophys. 615:1–9. 2017. View Article : Google Scholar
|
|
36
|
Zhang XN, Zhou J and Lu XJ: The long
noncoding RNA NEAT1 contributes to hepatocellular carcinoma
development by sponging miR-485 and enhancing the expression of the
STAT3. J Cell Physiol. 233:6733–6741. 2018. View Article : Google Scholar
|
|
37
|
Tan HY, Wang C, Liu G and Zhou X: Long
noncoding RNA NEAT1-modulated miR-506 regulates gastric cancer
development through targeting STAT3. J Cell Biochem. 120:4827–4836.
2019. View Article : Google Scholar
|
|
38
|
Banerjee K and Resat H: Constitutive
activation of STAT3 in breast cancer cells: A review. Int J Cancer.
138:2570–2578. 2016. View Article : Google Scholar :
|
|
39
|
Srivastava J and DiGiovanni J:
Non-canonical Stat3 signaling in cancer. Mol Carcinog. 5:1889–1898.
2016. View Article : Google Scholar
|
|
40
|
Binder S, Hösler N, Riedel D, Zipfel I,
Buschmann T, Kämpf C, Reiche K, Burger R, Gramatzki M, Hackermüller
J, et al: STAT3-induced long noncoding RNAs in multiple myeloma
cells display different properties in cancer. Sci Rep. 7:79762017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang
J, Zhpu J, Kang C, Li M and Jiang C: Long noncoding RNA NEAT1,
regulated by the EGFR pathway, contributes to glioblastoma
progression through the WNT/beta-catenin pathway by scaffolding
EZH2. Clin Cancer Res. 24:684–695. 2018. View Article : Google Scholar
|
|
42
|
Wang S, Zhang Q, Wang Q, Shen Q, Chen X,
Li Z, Zhou Y, Hou J, Xu B, Li N, et al: NEAT1 paraspeckle promotes
human hepatocellular carcinoma progression by strengthening
IL-6/STAT3 signaling. OncoImmunology. 7:e15039132018. View Article : Google Scholar : PubMed/NCBI
|
